These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9249851)

  • 1. Cost effectiveness in health care.
    Tyers GF
    Pacing Clin Electrophysiol; 1997 Jul; 20(7):1890-2. PubMed ID: 9249851
    [No Abstract]   [Full Text] [Related]  

  • 2. The economics of treating vasovagal syncope.
    Sutton R; Petersen ME
    Pacing Clin Electrophysiol; 1997 Mar; 20(3 Pt 2):849-50. PubMed ID: 9080526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of cardiac resynchronization therapy: results from the CARE-HF trial.
    Owen A
    Eur Heart J; 2006 May; 27(9):1125; author reply 1125-6. PubMed ID: 16497689
    [No Abstract]   [Full Text] [Related]  

  • 4. The cost-effectiveness of dual-chamber pacing.
    Parsonnet V
    Eur Heart J; 1996 Apr; 17(4):495-6. PubMed ID: 8733078
    [No Abstract]   [Full Text] [Related]  

  • 5. Can an expensive therapy save lives if the disease is not life threatening?
    Wijetunga M; Strickberger SA
    Heart Rhythm; 2005 Mar; 2(3):276. PubMed ID: 15851318
    [No Abstract]   [Full Text] [Related]  

  • 6. Pacing in perspective: concepts and controversies.
    Parsonnet V; Bernstein AD
    Circulation; 1986 Jun; 73(6):1087-93. PubMed ID: 3516446
    [No Abstract]   [Full Text] [Related]  

  • 7. First-in-human: leadless Micra transcatheter pacing system meets the Nanostim leadless cardiac pacing system.
    Boldt LH; Lacour P; Pieske B; Haverkamp W; Blaschke F
    Europace; 2018 Feb; 20(2):391. PubMed ID: 29016787
    [No Abstract]   [Full Text] [Related]  

  • 8. Cost-effectiveness of physiologic pacing: results of the Canadian Health Economic Assessment of Physiologic Pacing.
    O'Brien BJ; Blackhouse G; Goeree R; Healey JS; Roberts RS; Gent M; Connolly SJ
    Heart Rhythm; 2005 Mar; 2(3):270-5. PubMed ID: 15851317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remote follow-up of pacemakers in a selected population of debilitated elderly patients.
    Folino AF; Breda R; Calzavara P; Borghetti F; Comisso J; Iliceto S; Buja G
    Europace; 2013 Mar; 15(3):382-7. PubMed ID: 23118005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and usefulness of a second Micra transcatheter pacemaker implantation after battery depletion.
    Sánchez P; Apolo J; San Antonio R; Guasch E; Mont L; Tolosana JM
    Europace; 2019 Jun; 21(6):885. PubMed ID: 31081506
    [No Abstract]   [Full Text] [Related]  

  • 11. Yes to cardiac devices. But at what cost?
    Leyva F
    Europace; 2013 Mar; 15(3):313-4. PubMed ID: 23243130
    [No Abstract]   [Full Text] [Related]  

  • 12. Recommendations for pacing.
    Sutton R; Perrins J; Clarke M; Cobbe SM; Charles RG
    BMJ; 1992 Dec; 305(6866):1432. PubMed ID: 1486315
    [No Abstract]   [Full Text] [Related]  

  • 13. Recommendations for pacing.
    Banning AP; Avery PG; McGurk LA; Fraser AG; Buchalter M
    BMJ; 1992 Dec; 305(6866):1431-2. PubMed ID: 1486314
    [No Abstract]   [Full Text] [Related]  

  • 14. Recommendations for pacing.
    Channon KM; Cripps TR; Ormerod O
    BMJ; 1992 Dec; 305(6866):1431; author reply 1432. PubMed ID: 1301052
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiac resynchronization therapy for congestive heart failure.
    McAlister F; Ezekowitz J; Wiebe N; Rowe B; Spooner C; Crumley E; Hartling L; Kaul P; Nichol G; Klassen T
    Evid Rep Technol Assess (Summ); 2004 Nov; (106):1-8. PubMed ID: 15612141
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical trials for cardiac pacing in bradycardia: the end or the beginning?
    Tse HF; Lau CP
    Circulation; 2006 Jul; 114(1):3-5. PubMed ID: 16818826
    [No Abstract]   [Full Text] [Related]  

  • 17. Tilt testing is more cost-effective than implantable loop recorder monitoring as a means of directing pacing therapy in people with recurrent episodes of suspected vasovagal syncope that affect their quality of life or present a high risk of injury.
    Davis S; Westby M; Petkar S; Pitcher D
    Heart; 2013 Jun; 99(11):805-10. PubMed ID: 23236029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reimbursement for cardiac pacing.
    Fyke FE
    Pacing Clin Electrophysiol; 1992 Jul; 15(7):1091-2. PubMed ID: 1378602
    [No Abstract]   [Full Text] [Related]  

  • 19. Potential costs of cardiac re-synchronisation therapy for chronic heart failure in Scotland.
    Leslie SJ; Paudyal L; Grubb NR; Denvir MA
    Scott Med J; 2005 Nov; 50(4):179-80. PubMed ID: 16374987
    [No Abstract]   [Full Text] [Related]  

  • 20. Issues in cardiac pacing: can agism be justified?
    Payne GE; Skehan JD
    Br Heart J; 1994 Aug; 72(2):102-3. PubMed ID: 7917679
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.